Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Reactivity of 9-aminoacridine drug quinacrine with glutathione limits its antiprion activity.

Šafařík M, Moško T, Zawada Z, Šafaříková E, Dračínský M, Holada K, Šebestík J.

Chem Biol Drug Des. 2016 Dec 9. doi: 10.1111/cbdd.12918. [Epub ahead of print]

PMID:
27933730
2.

Expression of the cellular prion protein affects posttransfusion recovery and survival of red blood cells in mice.

Glier H, Simak J, Panigaj M, Gelderman MP, Vostal JG, Holada K.

Transfusion. 2015 Nov;55(11):2590-6. doi: 10.1111/trf.13190. Epub 2015 May 30.

PMID:
26033638
3.
4.

The effect of protein corona composition on the interaction of carbon nanotubes with human blood platelets.

De Paoli SH, Diduch LL, Tegegn TZ, Orecna M, Strader MB, Karnaukhova E, Bonevich JE, Holada K, Simak J.

Biomaterials. 2014 Aug;35(24):6182-94. doi: 10.1016/j.biomaterials.2014.04.067. Epub 2014 May 13.

PMID:
24831972
5.

Toxicity of carboxylated carbon nanotubes in endothelial cells is attenuated by stimulation of the autophagic flux with the release of nanomaterial in autophagic vesicles.

Orecna M, De Paoli SH, Janouskova O, Tegegn TZ, Filipova M, Bonevich JE, Holada K, Simak J.

Nanomedicine. 2014 Jul;10(5):939-48. doi: 10.1016/j.nano.2014.02.001. Epub 2014 Feb 22.

PMID:
24566271
6.

Detection of the GPI-anchorless prion protein fragment PrP226* in human brain.

Dvorakova E, Vranac T, Janouskova O, Černilec M, Koren S, Lukan A, Nováková J, Matej R, Holada K, Čurin Šerbec V.

BMC Neurol. 2013 Sep 25;13:126. doi: 10.1186/1471-2377-13-126.

7.

Quinacrine reactivity with prion proteins and prion-derived peptides.

Zawada Z, Šafařík M, Dvořáková E, Janoušková O, Březinová A, Stibor I, Holada K, Bouř P, Hlaváček J, Sebestík J.

Amino Acids. 2013 May;44(5):1279-92. doi: 10.1007/s00726-013-1460-x. Epub 2013 Jan 23.

PMID:
23340659
8.

Photodynamic inactivation of prions by disulfonated hydroxyaluminium phthalocyanine.

Janouskova O, Rakusan J, Karaskova M, Holada K.

J Gen Virol. 2012 Nov;93(Pt 11):2512-7. doi: 10.1099/vir.0.044727-0. Epub 2012 Aug 1.

PMID:
22855785
9.

Deletion of protease-activated receptor 2 prolongs survival of scrapie-inoculated mice.

Matej R, Olejar T, Janouskova O, Holada K.

J Gen Virol. 2012 Sep;93(Pt 9):2057-61. doi: 10.1099/vir.0.043877-0. Epub 2012 Jun 13.

PMID:
22694901
10.

Blood storage affects the detection of cellular prion protein on peripheral blood leukocytes and circulating dendritic cells in part by promoting platelet satellitism.

Glier H, Holada K.

J Immunol Methods. 2012 Jun 29;380(1-2):65-72. doi: 10.1016/j.jim.2012.04.002. Epub 2012 Apr 13.

PMID:
22522115
11.

Gerstmann-Sträussler-Scheinker syndrome with the P102L pathogenic mutation presenting as familial Creutzfeldt-Jakob disease: a case report and review of the literature.

Rusina R, Fiala J, Holada K, Matějčková M, Nováková J, Ampapa R, Koukolík F, Matěj R.

Neurocase. 2013;19(1):41-53. doi: 10.1080/13554794.2011.654215. Epub 2012 Apr 12.

PMID:
22494260
12.

Development of monoclonal antibodies specific for glycated prion protein.

Dvorakova E, Prouza M, Janouskova O, Panigaj M, Holada K.

J Toxicol Environ Health A. 2011;74(22-24):1469-75. doi: 10.1080/15287394.2011.618976.

13.

Expression of prion protein in mouse erythroid progenitors and differentiating murine erythroleukemia cells.

Panigaj M, Glier H, Wildova M, Holada K.

PLoS One. 2011;6(9):e24599. doi: 10.1371/journal.pone.0024599. Epub 2011 Sep 2.

14.

Carbon nanotubes activate store-operated calcium entry in human blood platelets.

Lacerda SH, Semberova J, Holada K, Simakova O, Hudson SD, Simak J.

ACS Nano. 2011 Jul 26;5(7):5808-13. doi: 10.1021/nn2015369. Epub 2011 Jun 8.

PMID:
21639133
15.

Underestimation of the expression of cellular prion protein on human red blood cells.

Panigaj M, Brouckova A, Glierova H, Dvorakova E, Simak J, Vostal JG, Holada K.

Transfusion. 2011 May;51(5):1012-21. doi: 10.1111/j.1537-2995.2010.02924.x. Epub 2010 Nov 8.

PMID:
21058954
16.

Binding of prion antibodies to white blood cells of nonhuman primates and the existence of washable pool of cellular prion protein associated with lymphocytes in peripheral blood.

Holada K, Glierova H, Janouskova O.

Transfusion. 2010 Sep;50(9):2063-5; author reply 2065-6. doi: 10.1111/j.1537-2995.2010.02707.x. No abstract available.

PMID:
21050226
17.

Cellular prion protein in blood platelets associates with both lipid rafts and the cytoskeleton.

Brouckova A, Holada K.

Thromb Haemost. 2009 Nov;102(5):966-74. doi: 10.1160/TH09-02-0074.

PMID:
19888536
18.

Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors.

Semberova J, De Paoli Lacerda SH, Simakova O, Holada K, Gelderman MP, Simak J.

Nano Lett. 2009 Sep;9(9):3312-7. doi: 10.1021/nl901603k.

PMID:
19736974
19.

Production, purification and oxidative folding of the mouse recombinant prion protein.

Pavlícek A, Bednárová L, Holada K.

Folia Microbiol (Praha). 2007;52(4):391-7.

PMID:
18062188
20.

Reduced erythroid cell and erythropoietin production in response to acute anemia in prion protein-deficient (Prnp-/-) mice.

Zivny JH, Gelderman MP, Xu F, Piper J, Holada K, Simak J, Vostal JG.

Blood Cells Mol Dis. 2008 May-Jun;40(3):302-7. Epub 2007 Oct 26.

PMID:
17964827

Supplemental Content

Loading ...
Support Center